Decoding the cGAS–STING–eosinophils predictive and natural therapeutic molecular signature in burn injury progression and keloid formation: insights from artificial intelligence-driven multiomics - Report - MDSpire
Advertisement
Decoding the cGAS–STING–eosinophils predictive and natural therapeutic molecular signature in burn injury progression and keloid formation: insights from artificial intelligence-driven multiomics
Clinical Report: cGAS–STING Pathway and Eosinophils in Burn Injury and Keloids
Overview
This study investigates the role of the cGAS–STING pathway and eosinophils in the progression of burn injuries and keloid formation. It identifies a gene signature associated with these processes and suggests CCL5 as a potential therapeutic target.
Background
Burn injuries lead to complex inflammatory responses that can result in keloid formation, a challenging condition characterized by excessive scar tissue. Understanding the molecular mechanisms involved, particularly the cGAS–STING pathway and eosinophil activity, is crucial for developing predictive biomarkers and targeted therapies for affected patients.
Data Highlights
No numerical data or trial data provided in the article.
Key Findings
The study identifies a cGAS–STING pathway and eosinophil (CE)-associated gene signature predictive of keloid formation in burn injury patients.
CCL5 is identified as an up-regulated pathogenic factor in keloid formation.
Icariin is suggested as a therapeutic target for keloid pathogenesis related to CCL5.
Machine learning models were developed to identify predictive hub genes involved in keloid formation.
Single-cell analysis revealed the pathogenic role of eosinophils in keloid tissue.
Clinical Implications
The findings suggest that monitoring CCL5 levels may help predict keloid formation in burn injury patients. Additionally, targeting the cGAS–STING pathway and eosinophils could offer new therapeutic strategies for managing keloids.
Conclusion
This study provides novel insights into the molecular mechanisms of keloid formation in burn injury patients, highlighting the potential for targeted therapies based on identified biomarkers.
